When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Seattle Genetics & Astellas team up with Merck in first-line urothelial cancer
Merck & Company Inc.
Seattle Genetics (NASDAQ:SGEN) and development partner Astellas Pharma (OTCPK:ALPMF) will collaborate with Merck (NYSE:MRK) on a Phase 3 clinical trial evaluating the combination of antibody-drug conjugate enfortumab vedotin and Keytruda (pembrolizumab) in treatment-naïve patients with metastatic urothelial cancer.
More news on: Seattle Genetics, Inc., Astellas Pharma Inc., Merck & Co., Inc., Healthcare stocks news,